Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

Compare

29.40

-0.29 (-0.98%)

At close: Oct 29, 2025, 4:00 PM EDT

29.40

0.00 (0.00%)

After-hours: Oct 29, 2025, 4:36 PM EDT

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	267.92	179.28	115.78	115.74	138.74	108.62	Upgrade
Other Revenue	-	-	0.1	-	-	-	Upgrade
Revenue	267.92	179.28	115.88	115.74	138.74	108.62	Upgrade
Revenue Growth (YoY)	105.62%	54.71%	0.12%	-16.57%	27.73%	83.21%	Upgrade
Cost of Revenue	46.11	42.03	31.63	62.02	66.32	61	Upgrade
Gross Profit	221.81	137.25	84.25	53.72	72.42	47.63	Upgrade
Selling, General & Admin	113.54	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Expenses	117.23	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Income	104.59	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
Interest Expense	-7.74	-7.92	-6.87	-3.71	-4.86	-1.35	Upgrade
Interest & Investment Income	2.29	2.09	2.27	0.68	0.05	0.58	Upgrade
EBT Excluding Unusual Items	99.14	18.37	-26.09	-61.75	-24.29	-29.74	Upgrade
Merger & Restructuring Charges	-	-	-	-1.32	-3.52	-	Upgrade
Other Unusual Items	-	-	1	4.5	10.5	-	Upgrade
Pretax Income	99.14	18.37	-25.09	-58.57	-17.31	-29.74	Upgrade
Income Tax Expense	1.32	0.88	-	-	0.61	-	Upgrade
Net Income	97.82	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Net Income to Common	97.82	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Shares Outstanding (Basic)	18	18	17	17	17	17	Upgrade
Shares Outstanding (Diluted)	18	18	17	17	17	17	Upgrade
Shares Change (YoY)	2.96%	1.64%	2.07%	-0.00%	1.03%	0.81%	Upgrade
EPS (Basic)	5.52	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
EPS (Diluted)	5.43	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
Free Cash Flow	65.79	31.44	-5.74	-74.21	5.25	-53.45	Upgrade
Free Cash Flow Per Share	3.65	1.78	-0.33	-4.35	0.31	-3.17	Upgrade
Gross Margin	82.79%	76.56%	72.70%	46.41%	52.20%	43.84%	Upgrade
Operating Margin	39.04%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Profit Margin	36.51%	9.75%	-21.65%	-50.61%	-12.91%	-27.38%	Upgrade
Free Cash Flow Margin	24.56%	17.53%	-4.96%	-64.11%	3.79%	-49.20%	Upgrade
EBITDA	107.01	26.42	-20.25	-57.73	-18.31	-28.27	Upgrade
EBITDA Margin	39.94%	14.74%	-17.48%	-49.88%	-13.20%	-26.02%	Upgrade
D&A For EBITDA	2.43	2.23	1.24	1	1.16	0.71	Upgrade
EBIT	104.59	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
EBIT Margin	39.04%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Effective Tax Rate	1.33%	4.80%	-	-	-	-	Upgrade
Revenue as Reported	267.92	179.28	116.88	120.24	149.24	108.62	Upgrade

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q